| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |